Together, these approaches aim to establish PAK4 not only as a molecular link between metabolism and muscle homeostasis but also as a promising therapeutic target for the prevention of sarcopenia and related muscle‐wasting disorders. The gene discussed is PAK4; the disease is sarcopenia.